Breaking News Instant updates and real-time market news.

OLN

Olin

$26.07 /

-1.01 (-3.73%)

08:48
01/19/21
01/19
08:48
01/19/21
08:48

Olin to cease operations at its Tric and AnHCI facilities in Freeport

Olin Corporation announced that it has made the decision to cease operations of its Trichloroethylene, or Tric, and Anhydrous Hydrogen Chloride, or AnHCl, liquefaction facilities in Freeport, Texas, before the end of 2021. These actions are expected to be cash flow accretive. Olin expects to incur approximately $2M of restructuring charges in 2021, associated with these plans. "The actions taken today further our efforts to ensure we purposefully allocate capital spending and Olin people assets towards lifting ECU returns. As Olin transitions our industry-leading feedstock position to supply next-generation, environmentally sustainable refrigerants, we will exit the production of Tric, which is used to produce traditional refrigerants."

  • 29

    Jan

OLN Olin
$26.07 /

-1.01 (-3.73%)

12/28/20 Alembic Global
Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global
12/17/20 KeyBanc
Olin upgraded to Overweight on epoxy strength at KeyBanc
12/16/20 KeyBanc
Olin upgraded to Overweight from Sector Weight at KeyBanc
12/09/20 Wells Fargo
Olin upgraded to Overweight from Equal Weight at Wells Fargo

TODAY'S FREE FLY STORIES

Upgrade
J.B. Hunt upgraded to Buy on 'robust' demand at BofA » 07:08
03/04/21
03/04
07:08
03/04/21
07:08
JBHT

J.B. Hunt

$152.57 /

+1.7 (+1.13%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

06:58 Today BofA
J.B. Hunt upgraded to Buy from Neutral at BofA
01/26/21 Susquehanna
J.B. Hunt downgraded to Neutral from Positive at Susquehanna
01/26/21 Susquehanna
J.B. Hunt downgraded to Neutral from Positive at Susquehanna
01/21/21 Deutsche Bank
J.B. Hunt price target raised to $146 from $139 at Deutsche Bank
JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

Hot Stocks
Bombardier targets 2025 total revenues about $7.5B » 07:08
03/04/21
03/04
07:08
03/04/21
07:08
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

Targets 2025 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

02/16/21 Cowen
Bombardier downgraded to Underperform from Market Perform at Cowen
02/16/21 Scotiabank
Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank
02/12/21 National Bank
Bombardier price target lowered to C$0.70 from C$0.80 at National Bank
02/12/21 BMO Capital
Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

Upgrade
U.S. Xpress Enterprises upgraded to Buy from Underperform at BofA » 07:07
03/04/21
03/04
07:07
03/04/21
07:07
USX

U.S. Xpress Enterprises

$10.32 /

+0.47 (+4.77%)

BofA analyst Ken Hoexter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

07:02 Today BofA
Correction: U.S. Xpress Enterprises upgraded to Buy from Underperform at BofA
11/23/20 BofA
BofA cuts three truckers to Neutral, double downgrades U.S. Xpress
11/23/20 BofA
U.S. Xpress Enterprises downgraded to Underperform from Buy at BofA
10/15/20 Stifel
U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel
USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

Hot Stocks
Bally's CEO seeing 'markedly stronger consumer demand' in January, February » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
BALY

Bally's

$60.69 /

-2.15 (-3.42%)

George Papanier,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

02/24/21 Truist
Bally's price target raised to $80 from $65 at Truist
02/09/21 Stifel
Bally's price target raised to $60 from $50 at Stifel
01/14/21 KeyBanc
KeyBanc bullish on Bally's, initiates with an Overweight
01/13/21 KeyBanc
Bally's initiated with an Overweight at KeyBanc
BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

Hot Stocks
Bombardier expects business jet deliveries to begin gradual recovery in 2021 » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

Bombardier will host its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

02/16/21 Cowen
Bombardier downgraded to Underperform from Market Perform at Cowen
02/16/21 Scotiabank
Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank
02/12/21 National Bank
Bombardier price target lowered to C$0.70 from C$0.80 at National Bank
02/12/21 BMO Capital
Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

Earnings
Autolus Therapeutics reports 2020 EPS ($2.76), consensus ($2.67) » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
AUTL

Autolus Therapeutics

$6.44 /

-0.35 (-5.15%)

Reports 2020 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan
01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/07/21 Truist
Autolus Therapeutics price target lowered to $15 from $30 at Truist
01/07/21 Mizuho
Autolus Therapeutics price target lowered to $18 from $24 at Mizuho
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

  • 10
    Feb
Earnings
Shift4 Payments reports Q4 adjusted EPS (5c), consensus 2c » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
FOUR

Shift4 Payments

$71.06 /

-4.24 (-5.63%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

01/06/21 Wolfe Research
Shift4 Payments downgraded to Peer Perform from Outperform at Wolfe Research
01/06/21 BofA
Shift4 Payments double-downgraded to Underperform from Buy at BofA
12/21/20
Fly Intel: Top five analyst initiations
12/21/20 Piper Sandler
Shift4 Payments initiated with an Overweight at Piper Sandler
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

  • 03
    Dec
  • 11
    Sep
  • 05
    Jun
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

Recommendations
Splunk price target lowered to $206 from $220 at Barclays » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
SPLK

Splunk

$143.31 /

-5.69 (-3.82%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

06:39 Today Baird
Splunk price target lowered to $200 from $215 at Baird
05:58 Today Mizuho
Splunk price target lowered to $180 from $190 at Mizuho
03/03/21 Citi
Splunk assumed with a Neutral at Citi
03/02/21 RBC Capital
Splunk may see 'slight upside' in Q4 results, says RBC Capital
SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

Hot Stocks
KKR to acquire Integrated Specialty Coverages, terms undisclosed » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
KKR

KKR

$47.01 /

+0.55 (+1.18%)

Integrated Specialty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KKR KKR
$47.01 /

+0.55 (+1.18%)

KKR KKR
$47.01 /

+0.55 (+1.18%)

02/10/21 BMO Capital
KKR price target raised to $72 from $54 at BMO Capital
02/10/21 Wells Fargo
KKR price target raised to $54 from $46 at Wells Fargo
02/10/21 Citi
KKR price target raised to $61.50 from $52.50 at Citi
02/10/21 Barclays
KKR price target raised to $62 from $50 at Barclays
KKR KKR
$47.01 /

+0.55 (+1.18%)

  • 11
    Nov
KKR KKR
$47.01 /

+0.55 (+1.18%)

KKR KKR
$47.01 /

+0.55 (+1.18%)

Hot Stocks
Autolus Therapeutics announces key upcoming milestones » 07:05
03/04/21
03/04
07:05
03/04/21
07:05
AUTL

Autolus Therapeutics

$6.44 /

-0.35 (-5.15%)

Key Upcoming Clinical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan
01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/07/21 Truist
Autolus Therapeutics price target lowered to $15 from $30 at Truist
01/07/21 Mizuho
Autolus Therapeutics price target lowered to $18 from $24 at Mizuho
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

  • 10
    Feb
Recommendations
Snowflake price target lowered to $270 from $295 at Barclays » 07:05
03/04/21
03/04
07:05
03/04/21
07:05
SNOW

Snowflake

$246.86 /

-23.73 (-8.77%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

06:31 Today Citi
Snowflake price target lowered to $295 from $325 at Citi
06:10 Today Deutsche Bank
Snowflake upgraded to Buy with $300 price target at Deutsche Bank
06:03 Today Deutsche Bank
Snowflake upgraded to Buy from Hold at Deutsche Bank
01/21/21 Goldman Sachs
Snowflake initiated with a Neutral at Goldman Sachs
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

  • 16
    Sep
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

Hot Stocks
Soligenix announces progress in pre-clinical development of COVID-19 vaccine » 07:05
03/04/21
03/04
07:05
03/04/21
07:05
SNGX

Soligenix

$1.60 /

-0.045 (-2.74%)

Soligenix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNGX Soligenix
$1.60 /

-0.045 (-2.74%)

SNGX Soligenix
$1.60 /

-0.045 (-2.74%)

12/23/20 Alliance Global Partners
Soligenix price target lowered to $5.75 from $7.25 at Alliance Global Partners
12/04/20 B. Riley Securities
B. Riley sees 100% upside in Soligenix, starts with Buy rating
12/04/20 B. Riley Securities
Soligenix initiated with a Buy at B. Riley Securities
07/28/20 Dawson James
Soligenix downgraded to Neutral from Buy at Dawson James
SNGX Soligenix
$1.60 /

-0.045 (-2.74%)

Earnings
Purple Innovation sees Q1 revenue $160M-$170M, consensus $176.46M » 07:04
03/04/21
03/04
07:04
03/04/21
07:04
PRPL

Purple Innovation

$36.25 /

-1.64 (-4.33%)

Sees Q1 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
01/12/21 Wedbush
Purple Innovation price target raised to $38 from $32 at Wedbush
12/16/20 Truist
Purple Innovation initiated with a Buy at Truist
12/16/20 Evercore ISI
Purple Innovation initiated with an Outperform at Evercore ISI
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

Hot Stocks
Autolus Therapeutics expects cash to extend runway into 1H23 » 07:04
03/04/21
03/04
07:04
03/04/21
07:04
AUTL

Autolus Therapeutics

$6.44 /

-0.35 (-5.15%)

Autolus estimates that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan
01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/07/21 Truist
Autolus Therapeutics price target lowered to $15 from $30 at Truist
01/07/21 Mizuho
Autolus Therapeutics price target lowered to $18 from $24 at Mizuho
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

  • 10
    Feb
Syndicate
Fiverr cancels $700M follow-on offering due to market conditions  07:04
03/04/21
03/04
07:04
03/04/21
07:04
FVRR

Fiverr

$241.45 /

-38.15 (-13.64%)

 
ShowHide Related Items >><<
FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

02/19/21 UBS
Fiverr price target raised to $205 from $190 at UBS
02/19/21 JMP Securities
Fiverr price target raised to $340 from $190 at JMP Securities
02/19/21 Citi
Fiverr price target raised to $350 from $270 at Citi
02/18/21 Needham
Fiverr price target raised to $335 at Needham following quarterly results
FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

  • 04
    Mar
  • 29
    May
FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

Recommendations
Ituran price target raised to $26 from $23 at Barclays » 07:04
03/04/21
03/04
07:04
03/04/21
07:04
ITRN

Ituran

$21.97 /

+0.16 (+0.73%)

Barclays analyst Tavy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRN Ituran
$21.97 /

+0.16 (+0.73%)

ITRN Ituran
$21.97 /

+0.16 (+0.73%)

07/21/20 Jefferies
Ituran downgraded to Hold on South America exposure at Jefferies
07/21/20 Jefferies
Ituran downgraded to Hold from Buy at Jefferies
Earnings
Purple Innovation sees FY21 revenue $840M-$880M, consensus » 07:03
03/04/21
03/04
07:03
03/04/21
07:03
PRPL

Purple Innovation

$36.25 /

-1.64 (-4.33%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
01/12/21 Wedbush
Purple Innovation price target raised to $38 from $32 at Wedbush
12/16/20 Truist
Purple Innovation initiated with a Buy at Truist
12/16/20 Evercore ISI
Purple Innovation initiated with an Outperform at Evercore ISI
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

Earnings
Ciena reports Q1 EPS 52c, consensus 45c » 07:03
03/04/21
03/04
07:03
03/04/21
07:03
CIEN

Ciena

$50.58 /

-0.97 (-1.88%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIEN Ciena
$50.58 /

-0.97 (-1.88%)

CIEN Ciena
$50.58 /

-0.97 (-1.88%)

02/25/21 Citi
Ciena price target raised to $65 from $55 at Citi
01/21/21
Fly Intel: Top five analyst upgrades
01/21/21 BofA
Ciena upgraded to Buy from Neutral at BofA
01/21/21 BofA
Ciena upgraded to Buy from Neutral at BofA
CIEN Ciena
$50.58 /

-0.97 (-1.88%)

CIEN Ciena
$50.58 /

-0.97 (-1.88%)

CIEN Ciena
$50.58 /

-0.97 (-1.88%)

Hot Stocks
Becton Dickinson acquires GSL Solutions, terms undisclosed » 07:02
03/04/21
03/04
07:02
03/04/21
07:02
BDX

Becton Dickinson

$241.76 /

-3.005 (-1.23%)

Becton Dickinson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$241.76 /

-3.005 (-1.23%)

BDX Becton Dickinson
$241.76 /

-3.005 (-1.23%)

02/12/21 Wells Fargo
Wells Fargo sees only 'small chance' of positive FDA panel for Becton
02/05/21 Citi
Becton Dickinson price target raised to $280 from $273 at Citi
02/04/21 Piper Sandler
Becton Dickinson price target raised to $280 from $275 at Piper Sandler
12/15/20
Fly Intel: Top five analyst downgrades
BDX Becton Dickinson
$241.76 /

-3.005 (-1.23%)

  • 21
    May
BDX Becton Dickinson
$241.76 /

-3.005 (-1.23%)

BDX Becton Dickinson
$241.76 /

-3.005 (-1.23%)

Recommendations
Descartes Systems price target raised to $63 from $59 at Barclays » 07:02
03/04/21
03/04
07:02
03/04/21
07:02
DSGX

Descartes Systems

/

+

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DSGX Descartes Systems
/

+

DSGX Descartes Systems
/

+

01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
11/13/20 Stephens
Descartes Systems upgraded to Overweight from Equal Weight at Stephens
09/11/20 Stifel
Descartes Systems price target raised to C$78 from C$63 at Stifel
09/11/20 Canaccord
Descartes Systems price target raised to C$65 from C$50 at Canaccord
DSGX Descartes Systems
/

+

DSGX Descartes Systems
/

+

Earnings
Bally's reports Q4 adjusted EPS 39c, consensus (8c) » 07:02
03/04/21
03/04
07:02
03/04/21
07:02
BALY

Bally's

$60.69 /

-2.15 (-3.42%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

02/24/21 Truist
Bally's price target raised to $80 from $65 at Truist
02/09/21 Stifel
Bally's price target raised to $60 from $50 at Stifel
01/14/21 KeyBanc
KeyBanc bullish on Bally's, initiates with an Overweight
01/13/21 KeyBanc
Bally's initiated with an Overweight at KeyBanc
BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

Initiation
American Outdoor Brands initiated with a Buy at B. Riley Securities » 07:02
03/04/21
03/04
07:02
03/04/21
07:02
AOUT

American Outdoor Brands

$20.17 /

-0.58 (-2.80%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AOUT American Outdoor Brands
$20.17 /

-0.58 (-2.80%)

AOUT American Outdoor Brands
$20.17 /

-0.58 (-2.80%)

01/22/21
Fly Intel: Top five analyst upgrades
01/22/21 Wedbush
American Outdoor Brands upgraded to Outperform from Neutral at Wedbush
01/22/21 Wedbush
American Outdoor Brands upgraded to Outperform from Neutral at Wedbush
12/16/20 Lake Street
Lake Street ups American Outdoor Brands price target to $24 after Q2 report
AOUT American Outdoor Brands
$20.17 /

-0.58 (-2.80%)

AOUT American Outdoor Brands
$20.17 /

-0.58 (-2.80%)

AOUT American Outdoor Brands
$20.17 /

-0.58 (-2.80%)

Earnings
Purple Innovation reports Q4 adjusted EPS 7c, consensus 11c » 07:02
03/04/21
03/04
07:02
03/04/21
07:02
PRPL

Purple Innovation

$36.25 /

-1.64 (-4.33%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
01/12/21 Wedbush
Purple Innovation price target raised to $38 from $32 at Wedbush
12/16/20 Truist
Purple Innovation initiated with a Buy at Truist
12/16/20 Evercore ISI
Purple Innovation initiated with an Outperform at Evercore ISI
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

Recommendations
American Eagle price target raised to $37 from $31 at UBS » 07:01
03/04/21
03/04
07:01
03/04/21
07:01
AEO

American Eagle

/

+

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEO American Eagle
/

+

AEO American Eagle
/

+

06:49 Today Citi
American Eagle price target raised to $32 from $29 at Citi
02/24/21 Cowen
American Eagle upgraded to Outperform from Market Perform at Cowen
02/24/21 Cowen
American Eagle upgraded to Outperform from Market Perform at Cowen
01/25/21 RBC Capital
American Eagle upgraded to Outperform from Sector Perform at RBC Capital
AEO American Eagle
/

+

AEO American Eagle
/

+

AEO American Eagle
/

+

AEO American Eagle
/

+

Upgrade
CGI Inc. upgraded to Buy from Hold at Edward Jones » 07:01
03/04/21
03/04
07:01
03/04/21
07:01
GIB

CGI Inc.

$76.26 /

-1.97 (-2.52%)

Edward Jones analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIB CGI Inc.
$76.26 /

-1.97 (-2.52%)

GIB CGI Inc.
$76.26 /

-1.97 (-2.52%)

02/01/21 Barclays
CGI Inc. price target raised to $89 from $80 at Barclays
01/28/21 Canaccord
CGI Inc. price target raised to C$112 from C$105 at Canaccord
01/28/21 BMO Capital
CGI Inc. price target raised to C$115 from C$107 at BMO Capital
01/28/21 RBC Capital
CGI Inc. price target raised to C$115 from C$110 at RBC Capital
GIB CGI Inc.
$76.26 /

-1.97 (-2.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.